文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

理解并应对 COVID-19 背景下的疫苗犹豫:数字干预措施的制定。

Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.

机构信息

University of Nottingham, School of Medicine, Nottingham, UK.

National Institute for Health Research (NIHR) ARC Wessex, UK; University of Southampton, Department of Psychology, Southampton, UK.

出版信息

Public Health. 2021 Dec;201:98-107. doi: 10.1016/j.puhe.2021.10.006. Epub 2021 Oct 18.


DOI:10.1016/j.puhe.2021.10.006
PMID:34801843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8520885/
Abstract

OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75-90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY DESIGN: & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.

摘要

目的:严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)于 2019 年末被发现,迅速传播至 200 多个国家,导致全球近 200 万人死亡。安全有效的疫苗的出现为疫情结束提供了出路,需要接种疫苗的人群达到 75-90%才能实现群体保护。疫苗犹豫对疫苗的推广存在问题;全球报告表明,只有 73%的人口可能同意接种疫苗。因此,迫切需要制定公平和可及的干预措施,以解决人群层面的疫苗犹豫问题。

研究设计和方法:我们报告了一种可扩展的数字干预措施的开发,旨在解决 COVID-19 疫苗犹豫问题,并提高英国 COVID-19 疫苗的接种率。该干预措施以动机访谈(MI)原则为指导,包括一系列针对疫苗犹豫个体的 10 个关键问题的治疗对话。干预措施的开发是线性进行的,共分为四个阶段。在第一阶段,我们通过分析现有调查数据、快速系统文献综述和公众参与研讨会,确定了 COVID-19 疫苗犹豫的常见原因。第二阶段包括对医学、免疫学和公共卫生专家的定性访谈。对数据的快速内容和主题分析提供了针对常见疫苗问题的循证回应。第三阶段涉及通过与心理和数字行为改变专家的研讨会开发治疗对话。通过 MI 原则开发对话,以解决问题,包括接受抵触情绪和支持自我效能感。最后,第四阶段涉及对话的数字化和与公众成员的试点测试。

讨论:该数字干预措施提供了一种基于 MI 原则的循证方法来解决疫苗犹豫问题。对话是用户选择的,允许在非评判的环境中探索与犹豫相关的相关问题。基于文本的内容和数字格式允许快速修改不断变化的信息,并可进行扩展以更广泛地传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/a4d2a582d6fa/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/19e203a9403f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/08872c4b11a6/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/a4d2a582d6fa/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/19e203a9403f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/08872c4b11a6/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7cc/8520885/a4d2a582d6fa/figs2_lrg.jpg

相似文献

[1]
Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.

Public Health. 2021-12

[2]
Mobile Health-Based Motivational Interviewing to Promote SARS-CoV-2 Vaccination in Rural Adults: Protocol for a Pilot Randomized Controlled Trial.

JMIR Res Protoc. 2025-4-28

[3]
Interventions to increase COVID-19 vaccine uptake: a scoping review.

Cochrane Database Syst Rev. 2022-8-3

[4]
Addressing vaccine hesitancy and resistance for COVID-19 vaccines.

Int J Nurs Stud. 2022-7

[5]
Motivational Interviewing Strategies for Addressing COVID-19 Vaccine Hesitancy.

J Am Board Fam Med. 2022

[6]
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.

Trials. 2021-9-6

[7]
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.

J Infect Public Health. 2022-7

[8]
COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.

JMIR Public Health Surveill. 2023-4-13

[9]
COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.

Mult Scler Relat Disord. 2021-9

[10]
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.

Hum Vaccin Immunother. 2022-11-30

引用本文的文献

[1]
Factors shaping Covid-19 vaccine acceptability among young people in South Africa and Nigeria: An exploratory qualitative study.

PLOS Glob Public Health. 2025-3-18

[2]
Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions.

Front Public Health. 2025-2-17

[3]
[Not Available].

J Prev Med Hyg. 2024-6-30

[4]
A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce.

Front Public Health. 2024

[5]
A Theory and Evidence-Based Artificial Intelligence-Driven Motivational Digital Assistant to Decrease Vaccine Hesitancy: Intervention Development and Validation.

Vaccines (Basel). 2024-6-25

[6]
COVID-19 ethics: unique aspects and a review as of early 2024.

Monash Bioeth Rev. 2024-6

[7]
Understanding COVID-19 vaccine hesitancy in the Hispanic adult population of South Carolina: a complex mixed-method design evaluation study.

BMC Public Health. 2023-11-28

[8]
COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition.

NPJ Vaccines. 2023-10-5

[9]
Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review.

Vaccines (Basel). 2023-8-15

[10]
Using the '4Ps' social marketing strategy to overcome vaccination hesitancy: COVID-19 vaccine coverage in a Chinese college as an example.

Saudi Med J. 2023-6

本文引用的文献

[1]
When it is available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in Nigeria.

Pan Afr Med J. 2021

[2]
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study.

Brain Behav Immun. 2021-5

[3]
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles.

Ann Intern Med. 2021-6

[4]
A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic.

Vaccines (Basel). 2021-1-20

[5]
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review.

Vaccines (Basel). 2020-12-30

[6]
The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts.

Lancet Psychiatry. 2021-2

[7]
COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II.

Psychol Med. 2022-10

[8]
COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey.

Hum Vaccin Immunother. 2021-6-3

[9]
WITHDRAWN: Vaccine hesitancy in Maltese family physicians and their trainees vis-à-vis influenza and novel COVID-19 vaccination.

Early Hum Dev. 2020-11-12

[10]
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.

Lancet. 2020-11-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索